Position in BIVI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,174,613
+$1,069,304 QoQ
Shares Held
605,471
+704.9% QoQ
Ownership
8.03%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 36 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,716,237,057 across 522 Biotechnology names. BIVI ranks #243 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in BIVI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-07-31 | $1,363,169 | 896,822 | Shares | Sole | 2026-08-07 | |
| 2026-06-30 | $1,174,615 | 605,472 | Shares | Sole | 2026-08-07 | |
| 2026-06-30 | $1,174,613 | 605,471 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $105,309 | 75,221 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $69,857 | 60,222 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $57,563 | 30,297 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $5,110 | 5,525 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $4,762 | 4,862 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $50,252 | 25,126 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $3,313 | 2,761 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $4,958 | 12,369 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $13,012 | 24,601 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $104,609 | 83,025 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $188,662 | 55,327 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $158,619 | 36,803 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $221,058 | 27,359 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $173,643 | 22,348 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,236 | 2,103 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,175 | 1,500 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $7,080 | 1,500 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $6,759 | 1,502 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $534 | 80 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $542 | 32 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $908 | 47 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $13,856 | 800 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $7,608 | 800 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||